| 11691970 |
Pyrazolopyridinone compounds |
Haibing GUO, Zhao-Kui Wan, Luoheng Qin, Qian Liu |
2023-07-04 |
| 11639350 |
Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections |
Zhao-Kui Wan, Yimin Jiang, Xuedong Dai, Qian Liu, Gang Deng +1 more |
2023-05-02 |
| 11384075 |
Quinolinone compounds |
Haibing GUO, Zhao-Kui Wan, Luoheng Qin, Qian Liu |
2022-07-12 |
| 11384099 |
Pyrazolopyridinone compounds |
Haibing GUO, Zhao-Kui Wan, Luoheng Qin, Qian Liu |
2022-07-12 |
| 11053235 |
Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases |
Gang Deng, Yimin Jiang, Qian Liu, Chao Liang, Zhao-Kui Wan +2 more |
2021-07-06 |
| 9193736 |
PDE 10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2015-11-24 |
| 8796256 |
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators |
Gilles Bignan, Micheal Gaul, Hui Huang, Xun Li, Raymond J. Patch +5 more |
2014-08-05 |
| 7951829 |
Benzimidazole modulators of VR1 |
Mark R. Player, Scott L. Dax, William H. Parsons, Michael Brandt, Raul Calvo +8 more |
2011-05-31 |
| 7612211 |
Benzimidazole TRPV1 inhibitors |
Daniel Parks, William H. Parsons, Sharmila Patel, Mark R. Player |
2009-11-03 |
| 7326788 |
Quinolinone derivatives as inhibitors of c-fms kinase |
Mark Wall, Mark R. Player, Raymond J. Patch, Sanath K. Meegalla, Jian Liu +3 more |
2008-02-05 |
